The worldwide proteomics sector is currently experiencing significant expansion, driven by increasing demand for precision medicine and a more extensive understanding of disease pathways. Recent directions point towards an evolution toward large-scale proteomics workflows, particularly supported by advancements in mass analysis technology. Moreover